Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Open-market sale SVP, Chief Commercial Officer sold 7,474 shares at $28.26 ($211,203)
  2. 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
  3. 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
  4. 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
  5. 4 Shares withheld for taxes Director gave up 795 shares (to pay taxes)
  6. 4 Shares withheld for taxes Director gave up 695 shares (to pay taxes)
  7. 4 Exercise or conversion Director acquired 7,585 shares (option exercise)
  8. 4 Shares withheld for taxes Director gave up 795 shares (to pay taxes)
  9. 4 Shares withheld for taxes Director gave up 3,945 shares (to pay taxes)
  10. 4 Exercise or conversion Director acquired 7,585 shares (option exercise)
  11. 4 Shares withheld for taxes Director gave up 905 shares (to pay taxes)
  12. 4 Shares withheld for taxes Director gave up 347 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,029 shares (to pay taxes)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 50,000 shares at $29.15 ($1,457,475)
  17. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $27.22 ($680,380)
  18. 4 Open-market sale Director and CEO, Alkermes plc sold 347,257 shares at an average $27.98 ($9,717,784)
  19. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $28.62 ($715,415)
  20. 4 Open-market sale Director sold 10,000 shares at $29.23 ($292,330)

Page 13 of 67 · 1,323 filings